X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10017) 10017
Book Chapter (58) 58
Newspaper Article (55) 55
Dissertation (15) 15
Web Resource (8) 8
Conference Proceeding (7) 7
Book / eBook (6) 6
Book Review (4) 4
Newsletter (4) 4
Publication (4) 4
Magazine Article (3) 3
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7317) 7317
male (2799) 2799
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (2618) 2618
female (2609) 2609
hematology (2393) 2393
cardiac & cardiovascular systems (2195) 2195
middle aged (2033) 2033
index medicus (1979) 1979
platelet aggregation inhibitors - therapeutic use (1667) 1667
aged (1664) 1664
animals (1646) 1646
peripheral vascular disease (1469) 1469
platelets (1219) 1219
treatment outcome (1185) 1185
abciximab (1122) 1122
glycoprotein-iib-iiia (1109) 1109
blood platelets - metabolism (1102) 1102
platelet aggregation - drug effects (1044) 1044
adult (998) 998
platelet aggregation inhibitors - pharmacology (956) 956
percutaneous coronary intervention (924) 924
thrombosis (921) 921
angioplasty (885) 885
glycoproteins (875) 875
blood platelets - drug effects (864) 864
angioplasty, balloon, coronary (847) 847
acute coronary syndromes (824) 824
acute myocardial-infarction (817) 817
aggregation (807) 807
risk factors (773) 773
unstable angina (767) 767
stents (762) 762
platelet aggregation (742) 742
activation (701) 701
antibodies, monoclonal - therapeutic use (697) 697
glycoprotein iib/iiia inhibitors (697) 697
fibrinogen (696) 696
platelet glycoprotein gpiib-iiia complex - metabolism (696) 696
myocardial infarction - therapy (691) 691
biochemistry & molecular biology (689) 689
blood platelets - physiology (678) 678
pharmacology & pharmacy (671) 671
immunoglobulin fab fragments - therapeutic use (660) 660
heart attacks (642) 642
blood platelets (640) 640
platelet aggregation inhibitors - administration & dosage (640) 640
myocardial infarction - drug therapy (631) 631
flow cytometry (630) 630
tyrosine - analogs & derivatives (629) 629
time factors (625) 625
platelet activation (619) 619
aspirin (592) 592
mortality (580) 580
cardiology (555) 555
clopidogrel (554) 554
tirofiban (552) 552
platelet aggregation inhibitors - adverse effects (546) 546
fibrinogen - metabolism (542) 542
anticoagulants - therapeutic use (537) 537
platelet membrane glycoproteins - metabolism (537) 537
amino acid sequence (532) 532
myocardial-infarction (526) 526
drug therapy, combination (523) 523
receptor (519) 519
fibrinolytic agents - therapeutic use (515) 515
molecular sequence data (514) 514
myocardial infarction (512) 512
adhesion (500) 500
eptifibatide (489) 489
glycoprotein iib/iiia (476) 476
platelet (465) 465
inhibition (464) 464
monoclonal-antibody (461) 461
heparin (452) 452
medicine, general & internal (452) 452
electrocardiography (443) 443
binding (442) 442
platelet activation - drug effects (438) 438
mice (436) 436
cell biology (434) 434
dose-response relationship, drug (418) 418
drug therapy (417) 417
randomized controlled trials as topic (416) 416
therapy (413) 413
integrin (404) 404
ticlopidine - analogs & derivatives (399) 399
anticoagulants (387) 387
thrombin (386) 386
care and treatment (385) 385
thrombolytic therapy (385) 385
vonwillebrand-factor (384) 384
in vitro techniques (381) 381
coronary angiography (374) 374
acute disease (371) 371
heart attack (370) 370
antibodies, monoclonal - pharmacology (368) 368
von-willebrand-factor (368) 368
intervention (367) 367
prospective studies (363) 363
acute coronary syndrome (362) 362
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9734) 9734
German (135) 135
French (76) 76
Spanish (60) 60
Russian (56) 56
Japanese (54) 54
Chinese (41) 41
Italian (30) 30
Polish (16) 16
Portuguese (14) 14
Czech (7) 7
Danish (5) 5
Turkish (5) 5
Dutch (4) 4
Hungarian (4) 4
Bulgarian (3) 3
Hebrew (2) 2
Korean (2) 2
Serbian (2) 2
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2003, Volume 289, Issue 7, pp. 853 - 863
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2004, Volume 292, Issue 6, pp. 696 - 703
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2007, Volume 297, Issue 6, pp. 591 - 602
Journal Article
Heart, ISSN 1355-6037, 12/2008, Volume 94, Issue 12, pp. 1548 - 1558
Journal Article
Circulation, ISSN 0009-7322, 09/2006, Volume 114, Issue 13, pp. 1380 - 1387
Background - Glycoprotein (GP) IIb/IIIa inhibitors are beneficial in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS... 
Drugs | Women | Glycoproteins | Hemorrhage | Sex | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | MYOCARDIAL-INFARCTION | drugs | sex | AMERICAN-COLLEGE | RECEPTOR | glycoproteins | ACUTE CORONARY SYNDROMES | HEPARIN | GUSTO IV-ACS | TASK-FORCE | HEART-ASSOCIATION | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | hemorrhage | women | Hemorrhagic Disorders - epidemiology | Kidney Diseases - physiopathology | Humans | Peptides - pharmacokinetics | Tyrosine - analogs & derivatives | Peptides - administration & dosage | Dose-Response Relationship, Drug | Hemorrhagic Disorders - complications | Angina, Unstable - drug therapy | Kidney Diseases - diet therapy | Tyrosine - therapeutic use | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Blood Transfusion - utilization | Adult | Registries | Kidney Diseases - complications | Platelet Aggregation Inhibitors - pharmacokinetics | Tyrosine - pharmacokinetics | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cerebral Hemorrhage - chemically induced | Acute Disease | Disease Susceptibility | Glomerular Filtration Rate | Hemorrhage - therapy | Sex Characteristics | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Angina, Unstable - complications | Creatinine - blood | Hemorrhage - chemically induced | Tyrosine - administration & dosage | Peptides - therapeutic use | Practice Guidelines as Topic
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2193 - 2204
...:1 to receive bivalirudin or heparin plus a glycoprotein IIb/IIIa inhibitor (GPI; pharmacological randomisation... 
Internal Medicine | HARMONIZING OUTCOMES | MEDICINE, GENERAL & INTERNAL | BLOOD-TRANSFUSION | DOUBLE-BLIND | FOLLOW-UP | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PREMATURE DISCONTINUATION | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Confidence Intervals | Myocardial Infarction - mortality | Paclitaxel - pharmacology | Prospective Studies | Follow-Up Studies | Humans | Heparin - administration & dosage | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - therapy | Platelet Glycoprotein GPIIb-IIIa Complex - administration & dosage | Time Factors | Electrocardiography | Female | Drug Therapy, Combination | Stents | Angioplasty, Balloon - methods | Myocardial Infarction - diagnosis | Drug-Eluting Stents | Drug Administration Schedule | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon - mortality | Hirudins - adverse effects | Survival Analysis | Peptide Fragments - adverse effects | Bivalirudin | Research | Diagnosis | Heparin | Drug therapy | Comparative analysis | Health aspects | Heart attack | Heart attacks | Cardiology | Mortality
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
...). Objectives This study sought to evaluate the efficacy and safety of cangrelor compared with clopidogrel in subgroups that did and did not receive glycoprotein IIb/IIIa inhibitors (GPIs... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 12/2008, Volume 1, Issue 6, pp. 649 - 653
...), the benefit of adjusted antiplatelet therapy with glycoprotein (GP) IIb/IIIa antagonist administration during PCI for 1-month clinical outcome. Background... 
coronary stenting | glycoprotein IIb/IIIa antagonist | clopidogrel response | CARDIAC & CARDIOVASCULAR SYSTEMS | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Immunoglobulin Fab Fragments - adverse effects | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Coronary Artery Disease - blood | Angioplasty, Balloon, Coronary - adverse effects | Angioplasty, Balloon, Coronary - mortality | Time Factors | Platelet Glycoprotein GPIIb-IIIa Complex - metabolism | Ticlopidine - adverse effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Female | Aspirin - therapeutic use | Blood Platelets - drug effects | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Stents | Drug Resistance | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Risk Assessment | Kaplan-Meier Estimate | Treatment Outcome | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Disease-Free Survival | Coronary Artery Disease - therapy | Blood Platelets - metabolism | Aged | Hemorrhage - chemically induced | Index Medicus
Journal Article